What is the Impact Factor of Drugs?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Drugs is 14.7, ranking in quartile Q1 of Web of Science (SCIE).

Is Drugs indexed in Web of Science or Scopus?

Yes, Drugs is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 3.500 (Q1) and an H-index of 212.

Who publishes Drugs and what is the Article Processing Charge (APC)?

Drugs is published by Springer International Publishing. The estimated Article Processing Charge (APC) is approximately $3,992 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Drugs?

The official ISO-4 abbreviation of Drugs is "DRUGS" with common acronym "drua". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #549Top JournalHybrid

Drugs

Acronym:drua

•

Abbreviation (ISO):DRUGS

•

Identifier (ISSN):0012-6667(Print)/1179-1950(Online)

•

Publisher:Springer International Publishing

Official Website Submission Portal Compare

Clarivate IF (2026)

14.7↑ +0.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Drugs

WoS Q1

Annual Impact Factor Metric

Current (2026):14.7

Scopus SJR & RankScopus Q1

3.5

#549

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

212

212 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate0.8%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

159articles/year

30.18% Gold OA•52.8% Original Research

Aims & Scope

Stay up to date with the latest developments in therapeutics by reading the world’s most respected source of authoritative drug information. For over 40 years Drugs has been the definitive journal of drugs and therapeutics, providing independent and crucial information authored by leading international clinicians and researchers. Our prestigious and truly international Honorary Editorial Board ensures content of the highest quality to support clinical decision-making. Through a rigorous and comprehensive program of peer-reviewed evaluations, Drugs provides detailed and objective analysis covering the full spectrum of new and established drug therapies in all disease areas.

Topics Covered (Recognized by AI)

Medicine99.5%Internal medicine95.4%Biology90.8%Psychology66.3%Psychiatry63.9%Pharmacology55.3%Chemistry53.1%Genetics52.4%Biochemistry47.3%Pathology44%Nursing43.3%Pharmacotherapy41.8%Endocrinology35.8%Surgery34.6%Intensive care medicine29.1%Immunology26%Anesthesia21.4%

Primary Research Areas

Medicine Toxicology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank7/356

IndexSCIE

JCRSCIE2026

TOXICOLOGY

Rank2/106

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank4/356

IndexSCIE

JCISCIE2026

TOXICOLOGY

Rank1/106

IndexSCIE

Category	Index	Rank	Quartile
PHARMACOLOGY & PHARMACY	JCRSCIE	7/356	Q1
TOXICOLOGY	JCRSCIE	2/106	Q1
PHARMACOLOGY & PHARMACY	JCISCIE	4/356	Q1
TOXICOLOGY	JCISCIE	1/106	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF14.7

Articles / Year133

Total Citations129

2025

IF14.4

Articles / Year136

Total Citations1,381

2024

IF13

Articles / Year145

Total Citations3,328

2023

IF11.5

Articles / Year161

Total Citations6,537

2022

IF11.431

Articles / Year158

Total Citations8,823

Year	Impact Factor	Articles / Year	Total Citations
2026	14.7	133	129
2025	14.4	136	1,381
2024	13	145	3,328
2023	11.5	161	6,537
2022	11.431	158	8,823
2021	9.546	204	12,677
2020	6.189	203	14,647
2019	4.993	208	15,326
2018	4.69	170	12,802
2017	—	178	14,622
2016	—	153	9,098
2015	—	183	10,628

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #549Scopus Q1SCImago Profile

Scopus Coverage:1971-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q1

3.5

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

13.28

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,992 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations5,214

3-Year Documents408

Citable Documents390

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate37.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmacology (medical)Q1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

1区 (Zone 1)Medicine

Minor Category (Specific Field):

1区PHARMACOLOGY & PHARMACY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Drugs (acronym: drua, abbr: DRUGS, ISSN: 0012-6667) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer International Publishing in New Zealand since 1971. The periodical holds a Journal Impact Factor (JIF) of 14.7, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 3.500 (Q1), an H-index of 212.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 159 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,992 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.